[Federal Register Volume 76, Number 60 (Tuesday, March 29, 2011)]
[Notices]
[Page 17421]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-7299]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number NIOSH-227]


Request for Information on Conditions Relating to Cancer To 
Consider for the World Trade Center Health Program

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice and extension of public comment period.

-----------------------------------------------------------------------

SUMMARY: On March 8, 2011, the Director of the National Institute of 
Occupational Safety and Health (NIOSH) of the Centers for Disease 
Control and Prevention (CDC) published a notice in the Federal Register 
(76 FR 12740) requesting information from the public on three questions 
regarding conditions relating to cancer for consideration under the 
World Trade Center Health Program. Written comment was to be received 
by March 31, 2011. NIOSH has received comment about extending the 
request for information to include persons living and working in the 
affected area. In consideration of that comment, the Director of NIOSH 
is modifying one of the questions posed in the Federal Register and 
extending the public comment period to April 29, 2011.

DATES: Written or electronic comments must be received on or before 
April 29, 2011. Please refer to SUPPLEMENTARY INFORMATION for 
additional information.

ADDRESSES: You may submit comments, identified by docket number NIOSH-
227, by any of the following methods:
    <bullet> Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 
MS-C34, 4676 Columbia Parkway, Cincinnati, OH 45226.
    <bullet> Facsimile: (513) 533-8285.
    <bullet> E-mail: <a href="/cdn-cgi/l/email-protection#b1dfd8dec2d9d5ded2dad4c5f1d2d5d29fd6dec7"><span class="__cf_email__" data-cfemail="36585f59455e5259555d53427655525518515940">[email protected]</span></a>.

All information received in response to this notice will be available 
for public examination and copying at the NIOSH Docket Office, 4676 
Columbia Parkway, Cincinnati, Ohio 45226. The comment period for NIOSH-
227 will close on April 29, 2011. All comments received will be 
available on the NIOSH Docket Web page at http://www.cdc.gov/niosh/docket, and comments will be available in writing by request. NIOSH 
includes all comments received without change in the docket and the 
electronic docket, including any personal information provided.

FOR FURTHER INFORMATION CONTACT: Dori Reissman, M.D., NIOSH, Patriots 
Plaza Suite 9200, 395 E. St., SW., Washington, DC 20201, telephone 
(202) 245-0625 or e-mail <a href="/cdn-cgi/l/email-protection#a8c6c1c7dbc0ccc7cbc3cddce8cbcccb86cfc7de"><span class="__cf_email__" data-cfemail="2c4245435f4448434f4749586c4f484f024b435a">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The Director of the National Institute for 
Occupational Safety and Health (NIOSH) of the Centers for Disease 
Control and Prevention (CDC) serves as the World Trade Center (WTC) 
Program Administrator for certain functions related to the WTC Health 
Program established by the James Zadroga 9/11 Health and Compensation 
Act (Pub. L. 111-347). In accordance with Section 3312(a)(5)(A) of that 
Act, the WTC Program Administrator is conducting a review of all 
available scientific and medical evidence to determine if, based on the 
scientific evidence, cancer or a certain type of cancer should be added 
to the applicable list of health conditions covered by the World Trade 
Center Health Program.
    The WTC Program Administrator is requesting information on the 
following: (1) Relevant reports, publications, and case information of 
scientific and medical findings where exposure to airborne toxins, any 
other hazard, or any other adverse condition resulting from the 
September 11, 2001 terrorist attacks, is substantially likely to be a 
significant factor in aggravating, contributing to, or causing cancer 
or a type of cancer; (2) clinical findings from the Clinical Centers of 
Excellence providing monitoring and treatment services to WTC 
responders (i.e., those persons who performed rescue, recovery, clean-
up and remediation work on the WTC disaster sites) and community 
members directly exposed to the dust cloud, gases and vapors on 9/11/01 
and those living and working in the affected area; and (3) input on the 
scientific criteria to be used by experts to evaluate the weight of the 
medical and scientific evidence regarding such potential health 
conditions.

    Dated: March 22, 2011.
John Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2011-7299 Filed 3-28-11; 8:45 am]
BILLING CODE 4163-19-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>